- About Us
- Nano-Social Network
- Nano Consulting
- My Account
"This package is good for Australia, and good for the globe," Research Australia CEO Rebecca James said.
"It could help a new generation of health researchers take their discoveries a step closer to market."
"The challenge is to ensure that the package includes a focus on Australian medical science to support the development of a robust industry based on medical research."
"Health research and development can find solutions to help contain the growth in health costs, and ensure a healthy Australia into the future," Ms James said.
Ms James welcomed the proposed tax changes as encouragement for more R&D to be undertaken in Australia. Funding for nanotechnology could also contribute to better ways to diagnose and treat disease.
The statement which includes $500 million to extend eligibility for the 175 percent premium R&D tax concession, $351.8 million for Industry Productivity Centres and $21.5 million for a National Nanotechnology Strategy, offers the promise of an Australia which can continue to compete in the global marketplace.
"We look to these initiatives to further boost Australia's outstanding contribution towards improving global health," she said.
About Research Australia
Research Australia is a unique national alliance of over 190 member and donor organisations with a common mission to make health and medical research a higher national priority. For more information on Research Australia visit http://www.researchaustralia.org
For more information, please click here
Dr Stephanie Williams
Copyright © Research AustraliaIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Molecular phenomenon discovered by advanced NMR facility: Cutting edge technology has shown a molecule self-assembling into different forms when passing between solution state to solid state, and back again - a curious phenomenon in science - says research by the University of Wa February 22nd, 2017
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017
Harris & Harris Group Announces a Proposed Strategic Restructuring December 20th, 2016
New nano approach could cut dose of leading HIV treatment in half February 24th, 2017